Polyunsaturated Fatty Acids: What is Their Role in Treatment of Psychiatric Disorders?
- PMID: 31652770
- PMCID: PMC6862261
- DOI: 10.3390/ijms20215257
Polyunsaturated Fatty Acids: What is Their Role in Treatment of Psychiatric Disorders?
Abstract
In the central nervous system omega-3 fatty acids modulate cell signaling and affect dopaminergic and serotonergic pathways. On this basis, a new application for omega-3 fatty acids has been proposed, concerning the treatment of several psychiatric disorders. The present article is an update of a previous systematic review and is aimed to provide a complete report of data published in the period between 1980 and 2019 on efficacy and tolerability of omega-3 fatty acids in psychiatric disorders. In July 2019, an electronic search on PUBMED, Medline and PsychINFO of all RCTs, systematic reviews and meta-analyses on omega-3 fatty acids and psychiatric disorders without any filter or MESH restriction was performed. After eligibility processes, the final number of records included in this review was 126. One hundred and two of these studies were RCTs, while 24 were reviews and meta-analyses. The role of omega-3 fatty acids was studied in schizophrenia, major depression, bipolar disorder, anxiety disorders, obsessive-compulsive disorder, post-traumatic stress disorder, attention deficit hyperactivity disorder (ADHD), autism spectrum disorders, eating disorders, substance use disorder and borderline personality disorder. The main evidence of the efficacy of omega-3 fatty acids has been obtained in treating depressive symptoms in patients with major depression and, to a lesser degree, bipolar depression. Some efficacy was also found in early phases of schizophrenia in addition to antipsychotic treatment, but not in the chronic phases of psychosis. Small beneficial effects of omega-3 fatty acids were observed in ADHD and positive results were reported in a few trials on core symptoms of borderline personality disorder. For other psychiatric disorders results are inconsistent.
Keywords: adverse effects; efficacy; omega-3 fatty acids; polyunsaturated fatty acids; psychiatric disorders; randomized controlled trials.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid?Lipids Health Dis. 2007 Sep 18;6:21. doi: 10.1186/1476-511X-6-21. Lipids Health Dis. 2007. PMID: 17877810 Free PMC article. Review.
-
Supplementation with Omega-3 Fatty Acids in Psychiatric Disorders: A Review of Literature Data.J Clin Med. 2016 Jul 27;5(8):67. doi: 10.3390/jcm5080067. J Clin Med. 2016. PMID: 27472373 Free PMC article. Review.
-
Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce.World J Biol Psychiatry. 2022 Jul;23(6):424-455. doi: 10.1080/15622975.2021.2013041. Epub 2022 Mar 21. World J Biol Psychiatry. 2022. PMID: 35311615
-
Randomized placebo-controlled trials of omega-3 polyunsaturated fatty acids in psychiatric disorders: a review of the current literature.Curr Drug Discov Technol. 2013 Sep;10(3):245-53. doi: 10.2174/1570163811310030007. Curr Drug Discov Technol. 2013. PMID: 21838664 Review.
-
Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry.J Clin Psychiatry. 2006 Dec;67(12):1954-67. doi: 10.4088/jcp.v67n1217. J Clin Psychiatry. 2006. PMID: 17194275 Review.
Cited by
-
Nutraceuticals in Psychiatric Disorders: A Systematic Review.Int J Mol Sci. 2024 Apr 28;25(9):4824. doi: 10.3390/ijms25094824. Int J Mol Sci. 2024. PMID: 38732043 Free PMC article.
-
GWAS-identified bipolar disorder risk allele in the FADS1/2 gene region links mood episodes and unsaturated fatty acid metabolism in mutant mice.Mol Psychiatry. 2023 Jul;28(7):2848-2856. doi: 10.1038/s41380-023-01988-2. Epub 2023 Feb 21. Mol Psychiatry. 2023. PMID: 36806390 Free PMC article.
-
Involvement of kynurenine pathway between inflammation and glutamate in the underlying etiopathology of CUMS-induced depression mouse model.BMC Neurosci. 2022 Nov 10;23(1):62. doi: 10.1186/s12868-022-00746-4. BMC Neurosci. 2022. PMID: 36357867 Free PMC article.
-
Docosahexaenoic and Eicosapentaenoic Intervention Modifies Plasma and Erythrocyte Omega-3 Fatty Acid Profiles But Not the Clinical Course of Children With Autism Spectrum Disorder: A Randomized Control Trial.Front Nutr. 2022 Mar 29;9:790250. doi: 10.3389/fnut.2022.790250. eCollection 2022. Front Nutr. 2022. PMID: 35425788 Free PMC article.
-
Mental Health in Childhood and Adolescence: The Role of Polyunsaturated Fatty Acids.Biomedicines. 2021 Jul 21;9(8):850. doi: 10.3390/biomedicines9080850. Biomedicines. 2021. PMID: 34440053 Free PMC article. Review.
References
-
- Pusceddu M.M., Nolan Y.M., Green H.F., Robertson R.C., Stanton C., Kelly P., Cryan J.F., Dinan T.G. The Omega-3 polyunsaturated fatty acid docosahexaenoic acid (DHA) reverses corticosterone-induced changes in cortical neurons. Int. J. Neuropsychopharmacol. 2016;6:1–19. doi: 10.1093/ijnp/pyv130. - DOI - PMC - PubMed
-
- Calder P.C., Bosco N., Bourdet-Sicard R., Capuron L., Delzenne N., Doré J., Franceschi C., Lehtinen M.J., Recker T., Salvioli S., et al. Health relevance of the modification of low grade inflammation in ageing (inflammageing) and the role of nutrition. Ageing Res. Rev. 2017;40:95–119. doi: 10.1016/j.arr.2017.09.001. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical